Litcius/Paper detail

LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)

R.F. Salgado, A. Bardia, G. Curigliano, Xiaolong Hu, Rebecca Dent, J-Y Pierga, J. Tsurutani, H. Wildiers, G.R.R. Ricciardi, Caterina Marchiò, F. Penault-Llorca, Catherine Bor-Angelier, A. Andrzejuk-Cwik, Annie Darilay, Takayuki Matsuo, Rana Shami, F. Avery Jones, Giulia Viale

2024Annals of Oncology13 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHuman Epidermal Growth Factor Receptor 2Metastatic breast cancerHormone receptorBreast cancerInternal medicineOncologyReceptorDestiny (ISS module)CancerCancer researchAstronomyPhysicsHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesCancer Treatment and Pharmacology